Edwards Lifesciences Corp (EW)
86.69
-0.73
(-0.84%)
USD |
NYSE |
May 10, 16:00
86.70
+0.01
(+0.01%)
After-Hours: 20:00
Edwards Lifesciences Gross Profit (Quarterly): 1.213B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.213B |
December 31, 2023 | 1.177B |
September 30, 2023 | 1.130B |
June 30, 2023 | 1.187B |
March 31, 2023 | 1.130B |
December 31, 2022 | 1.090B |
September 30, 2022 | 1.065B |
June 30, 2022 | 1.104B |
March 31, 2022 | 1.042B |
December 31, 2021 | 1.020B |
September 30, 2021 | 998.50M |
June 30, 2021 | 1.042B |
March 31, 2021 | 923.20M |
December 31, 2020 | 895.40M |
September 30, 2020 | 859.90M |
June 30, 2020 | 686.80M |
March 31, 2020 | 863.60M |
December 31, 2019 | 887.90M |
September 30, 2019 | 801.60M |
June 30, 2019 | 782.90M |
March 31, 2019 | 761.20M |
December 31, 2018 | 743.00M |
September 30, 2018 | 681.70M |
June 30, 2018 | 697.50M |
March 31, 2018 | 661.20M |
Date | Value |
---|---|
December 31, 2017 | 653.20M |
September 30, 2017 | 608.20M |
June 30, 2017 | 630.70M |
March 31, 2017 | 667.90M |
December 31, 2016 | 554.50M |
September 30, 2016 | 538.00M |
June 30, 2016 | 556.80M |
March 31, 2016 | 517.00M |
December 31, 2015 | 495.20M |
September 30, 2015 | 468.80M |
June 30, 2015 | 458.20M |
March 31, 2015 | 454.30M |
December 31, 2014 | 457.60M |
September 30, 2014 | 439.30M |
June 30, 2014 | 423.90M |
March 31, 2014 | 376.50M |
December 31, 2013 | 392.20M |
September 30, 2013 | 367.40M |
June 30, 2013 | 393.60M |
March 31, 2013 | 375.70M |
December 31, 2012 | 388.30M |
September 30, 2012 | 336.20M |
June 30, 2012 | 352.20M |
March 31, 2012 | 331.90M |
December 31, 2011 | 310.60M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
686.80M
Minimum
Jun 2020
1.213B
Maximum
Mar 2024
995.06M
Average
1.031B
Median
Gross Profit (Quarterly) Benchmarks
Stryker Corp | 3.333B |
Align Technology Inc | 697.82M |
Abbott Laboratories | 5.501B |
Boston Scientific Corp | 2.647B |
Steris PLC | 602.59M |